JACC Case Rep. 2026 Jun 26:109018. doi: 10.1016/j.jaccas.2026.109018. Online ahead of print.
ABSTRACT
BACKGROUND: People living with HIV (PLWH) have increased atherosclerotic cardiovascular disease risk. Guidelines recommend statin therapy for PLWH aged 40 to 75 years with a 10-year atherosclerotic cardiovascular disease risk of ≥5%.
PROJECT RATIONALE: Statin prescribing is suboptimal in this population. We implemented a quality improvement initiative to identify barriers and increase statin prescribing in eligible PLWH.
PROJECT SUMMARY: Seventeen of 25 (68%) Kaiser Permanente HIV specialists were surveyed on barriers to statin prescribing and participated in a quality improvement initiative that provided monthly education and prescribing feedback. Statin prescriptions among PLWH aged 40 to 75 years were assessed before the intervention (June-December 2024) and during the intervention (January-June 2025) using interrupted time series. Seventeen of 25 specialists (68%) participated. Reported barriers included patient reluctance (71%), nonautomated risk calculation (58%), and limited resources (47%). Baseline statin prescribing was 44.1%. Monthly prescribing increased from 0.30% preintervention to 1.24% postintervention (P < 0.001), yielding 193 additional prescriptions.
TAKE-HOME MESSAGE: An intervention combining ongoing education with monthly performance feedback significantly improved statin prescribing rates among PLWH.
PMID:42363931 | DOI:10.1016/j.jaccas.2026.109018